News in the Life Sciences Industry | |
Results 361 - 380 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Oncopeptides has submitted an Investigational New Drug application to FDA for the second drug candidate from the PDC platform |
STOCKHOLM, Oct. 19, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA), for OPD5 - a second drug candidate based on the proprietary... Read more ›› |
By: PR Newswire Association LLC. - 19 Oct 2020 |
Related companies: Oncopeptides AB |
Amsterdam UMC chooses Sectra for enterprise-wide radiology imaging |
LINKÖPING, Sweden, Oct. 19, 2020 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has... Read more ›› |
By: PR Newswire Association LLC. - 19 Oct 2020 |
Related companies: Sectra AB |
CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis |
Read more ›› |
By: GlobenewsWire - 16 Oct 2020 |
Tarsus Pharmaceuticals Inc. Announces Pricing of Initial Public Offering |
Read more ›› |
By: GlobenewsWire - 16 Oct 2020 |
Related companies: Tarsus Products AB | Tarsus Pharmaceuticals, Inc. |
Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation |
Read more ›› |
By: GlobenewsWire - 16 Oct 2020 |
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody levels in preclinical studies |
Read more ›› |
By: GlobenewsWire - 15 Oct 2020 |
Acarix changes Certified Advisor to Redeye |
Read more ›› |
By: GlobenewsWire - 15 Oct 2020 |
Related companies: Acarix AB |
BioArctic winner of the Allbright Award 2020 |
STOCKHOLM, Oct. 15, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has been awarded the 2020 Allbright Award for its focused work with gender equality. The announcement was made on October 15 during Allbright's annual award ceremony in... Read more ›› |
By: PR Newswire Association LLC. - 15 Oct 2020 |
Related companies: BioArctic AB |
Aino Health AB (publ): Aino Health supports organizations with new product for return-to-work after the COVID-19 pandemic |
Read more ›› |
By: GlobenewsWire - 15 Oct 2020 |
Related companies: Aino Health AB (publ) |
BioInvent to present data on BI-1808, an anti-TNFR2 antibody, at the SITC 35th Anniversary Annual Meeting |
LUND, Sweden, Oct. 15, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announce that they will be presenting a poster... Read more ›› |
By: PR Newswire Association LLC. - 15 Oct 2020 |
Related companies: BioInvent International AB |
BioInvent and Transgene to present data on oncolytic virus BT-001 at the SITC 35th Anniversary Annual Meeting |
LUND, Sweden and STRASBOURG, France, Oct. 15, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris:... Read more ›› |
By: PR Newswire Association LLC. - 15 Oct 2020 |
Related companies: BioInvent International AB |
SI-BONE Announces Pricing of Public Offering of Common Stock |
Read more ›› |
By: GlobenewsWire - 15 Oct 2020 |
SI-BONE Announces Launch of Public Offering of Common Stock |
Read more ›› |
By: GlobenewsWire - 14 Oct 2020 |
Oncopeptides signs EUR 40 million loan agreement with the EIB |
STOCKHOLM, Oct. 14, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the company has entered into a loan agreement with the European Investment Bank (EIB), granting the company access to an unsecured loan facility of up to EUR40 M. The... Read more ›› |
By: PR Newswire Association LLC. - 14 Oct 2020 |
Related companies: Oncopeptides AB |
Moberg Pharma intends to submit a registration application in Europe in 2021 |
STOCKHOLM, Oct. 14, 2020 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announced today its decision to request pre-submission meetings with regulatory agencies, with the goal of submitting a registration application in the second half of 2021 in Europe. Read more ›› |
By: PR Newswire Association LLC. - 14 Oct 2020 |
Related companies: Moberg Pharma AB (Publ) |
Extraordinary general meeting in Cantargia AB (publ) |
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- The extraordinary general meeting in Cantargia on 13 October 2020 resolved in accordance with the following: Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Cantargia AB |
Orexo´s Nomination Committee for the Annual General Meeting 2021 |
UPPSALA, Sweden, Oct. 13, 2020 /PRNewswire/ -- Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020. Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Orexo AB |
Envirotainer Unleashes Free Shipment reports |
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- Envirotainer, the global market leader and the by far largest provider of temperature-controlled air freight solutions for pharmaceuticals, today announced that they open up unlimited and free access to shipment data for all their customers. The shipment... Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Envirotainer AB |
Enzymatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries |
Enzymatica has licensed to STADA exclusive rights to market and sell the common cold spray ViruProtect® (ColdZyme®) in Russia, Poland, Ukraine and 11 further countries in the CIS and Central Asia. |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: Enzymatica AB |
AlzeCure gets abstract on the NeuroRestore platform against Alzheimer's accepted for poster presentation at CTAD |
STOCKHOLM, Oct. 13, 2020 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced... Read more ›› |
By: PR Newswire Association LLC. - 13 Oct 2020 |
Related companies: AlzeCure Pharma AB |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 » |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT
Latest company news
Doptelet® (avatrombopag) approved in the EU for treatment of ITP